Growth Metrics

Immunocore Holdings (IMCR) Cash from Investing Activities (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed Cash from Investing Activities for 3 consecutive years, with -$880000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 75.14% to -$880000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$16.3 million through Dec 2025, up 95.4% year-over-year, with the annual reading at -$16.3 million for FY2025, 95.4% up from the prior year.
  • Cash from Investing Activities hit -$880000.0 in Q4 2025 for Immunocore Holdings, down from $5.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $9.7 million in Q1 2025 to a low of -$350.3 million in Q2 2024.
  • Historically, Cash from Investing Activities has averaged -$31.4 million across 3 years, with a median of -$854000.0 in 2024.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 25013.33% in 2024 and later soared 2356.28% in 2025.
  • Year by year, Cash from Investing Activities stood at -$817000.0 in 2023, then crashed by 333.29% to -$3.5 million in 2024, then surged by 75.14% to -$880000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for IMCR at -$880000.0 in Q4 2025, $5.3 million in Q3 2025, and -$30.4 million in Q2 2025.